Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group

被引:0
作者
机构
[1] Menzies School of Health Research and Charles Darwin University,The APMEN Vivax Working Group, Global and Tropical Health Division
关键词
Malaria; APMEN; Asia-Pacific; Elimination;
D O I
暂无
中图分类号
学科分类号
摘要
The Asia Pacific Malaria Elimination Network (APMEN) is a collaboration of 18 country partners committed to eliminating malaria from within their borders. Over the past 5 years, APMEN has helped to build the knowledge, tools and in-country technical expertise required to attain this goal. At its inaugural meeting in Brisbane in 2009, Plasmodium vivax infections were identified across the region as a common threat to this ambitious programme; the APMEN Vivax Working Group was established to tackle specifically this issue. The Working Group developed a four-stage strategy to identify knowledge gaps, build regional consensus on shared priorities, generate evidence and change practice to optimize malaria elimination activities. This case study describes the issues faced and the solutions found in developing this robust strategic partnership between national programmes and research partners within the Working Group. The success of the approach adopted by the group may facilitate similar applications in other regions seeking to deploy evidence-based policy and practice.
引用
收藏
相关论文
共 270 条
[1]  
Douglas NM(2014)Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia BMC Med. 12 217-57
[2]  
Pontororing GJ(2013)Evidence and implications of mortality associated with acute Clin Microbiol Rev 26 36-1967
[3]  
Lampah DA(2008) malaria Malar J. 7 148-1712
[4]  
Yeo TW(1999)Malaria morbidity in Papua Indonesia, an area with multidrug resistant Lancet 353 1965-1381
[5]  
Kenangalem E(2009) and Clin Infect Dis 48 1704-3309
[6]  
Poespoprodjo J(2008)Averting a malaria disaster Clin Infect Dis 46 1374-326
[7]  
Baird JK(2014)Vivax malaria: a major cause of morbidity in early infancy J Clin Microbiol 52 3303-410
[8]  
Karyana M(2015)Adverse pregnancy outcomes in an area where multidrug-resistant PLoS Negl Trop Dis. 9 e3413-991
[9]  
Burdarm L(2014) and Geneva 2014 113-1587
[10]  
Yeung S(2013) infections are endemic Malar J. 12 429-1384